Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

14.65
Delayed Data
As of Oct 20
 -0.15 / -1.01%
Today’s Change
8.77
Today|||52-Week Range
17.20
+20.58%
Year-to-Date

Today’s Trading

Previous close14.80
Today’s open14.90
Day’s range14.50 - 15.05
Volume401,814
Average volume (3 months)468,133
Market cap$794.3M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-739.19%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratioNM
Price/Sales4.86
Price/Book6.38

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...-0.01-0.06%
AKAOAchaogen Inc-0.45-3.14%
RETAReata Pharmaceutical...+1.01+3.18%
AKBAAkebia Therapeutics ...+0.10+0.56%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts